The National Health Regulatory Authority (NHRA) has licensed the first factory to produce medical face masks in Bahrain, as part of the kingdom’s efforts to enhance medical investments, especially those aimed at supporting its efforts to combat the novel coronavirus (COVID-19).
NHRA’s Chief Executive Officer, Mariam Adhbi Al-Jalahma, received Ziyad Janahi, the representative of “Aegis Medical” and handed over to him a certificate approving the factory as licensed manufacturers of medical N95 and PLY3 medical face masks in the kingdom.
Al-Jalahma said that based on the leadership’s directives, the NHRA is keen to attract and support investments in the health sector.
Deputy Chairman of the Board of Directors of “Aegis Medical”, Dawood Al-Hmood, lauded the cooperation of all the relevant authorities, particularly the NHRA, with the investors in the factory.
He appreciated the easy and smooth establishment procedures of the factory, and the full support of the Industry, Commerce and Tourism Ministry, praising the tax exemptions for medical products.
He pointed out that Bahrain’s open-market policy and investment-stimulating environment have encouraged the factory’s owners to set it in the kingdom, given its clear procedures and the electronic system provided for investors.
The 750-square-metre plant produces the highest standard medical face masks, using cutting-edge technologies, with a monthly production capacity of about two million high grade N95 medical face masks, and nearly three million surgical 3 PLY masks.
NHRA’s Safety Adviser, Nada Al Sayegh, said that the NHRA will ensure the registration of the factory across the GCC countries so as to enable it to supply the GCC market with medical face masks that are made according to the European and American safety and efficiency standards.